US FDA approves BridgeBio's drug for rare heart condition
The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...
BridgeBio Gets US Approval for Heart Drug to Compete with Pfizer
BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way ...
BridgeBio heart drug approved by FDA, setting up battle with Pfizer
The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market ...
STAT20h
BridgeBio wins FDA approval for heart disease drug
The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...
BridgeBio announces FDA approved Attruby for ATTR-CM patients
Pharma announced that the U.S. Food and Drug Administration approved Attruby, an orally-administered near-complete stabilizer ...
devdiscourse15h
FDA's Game-Changing Approvals and Global Health Alerts
The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...
STAT4h
‘We dodged a bullet’: Biotech and pharma react to selection of Marty Makary for FDA commissioner
It is fair to say that far more individuals aside from the commissioner are instrumental as far as the drug review and ...
CBS News2d
Are food recalls and outbreaks on the rise? FDA says U.S. food supply still "one of the safest in the world"
The Food and Drug Administration said Wednesday that the U.S. food supply is still "one of the safest in the world," in the wake of a number of foodborne disease outbreaks affecting items ranging ...
Zacks.com on MSN3d
Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
BAYRY enters into a collaboration and license agreement with Cytokinetics for the exclusive development and commercialization ...
FiercePharma2d
Biopharma status quo 'likely to persist' under Trump 2.0, though changes to IRA, FTC and more could be on the way: analyst
As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the ...
UPI2d
Survey: 1 in 3 Americans report being harmed by another's drinking, drug use
Tom's of Maine has received a warning from the Food and Drug Administration about a "black mold-like substance," as well as bacteria in the water, at the Sanford factory where its toothpaste is made.
Morningstar4d
The Best Biotech Stocks to Buy
The Food and Drug Administration has accepted BridgeBio’s new drug application for acoramidis with a Prescription Drug User Fee Act action date set for Nov. 29. If it receives regulatory ...